Chris Mason

Chris Mason

Company: Avrobio

Job title: Founder & Chief Scientific Officer

Seminars:

Q&A Panel Discussion: Exploring Different Genetic Approaches & Novel Targets for CNS Disorders 11:40 am

Read more

day: Day One

The Challenges & Opportunities of Targeting CNS Disorders with Lentiviral-Based Gene Therapy 11:20 am

Ex vivo lentiviral gene therapy enables the engraftment of microglia-like cells throughout the CNS Platform has demonstrated meaningful clinical effects in CNS in MLD and C-ALD patients AVROBIO preclinical data demonstrates therapeutic transgene expression in the brain across multiple indicationsRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.